Brendan Dickinson
General Partner / East Coast
Canaan Partners
Canaan General Partner leading the firm’s fintech practice, with emphasis on fintech infrastructure, platforms, products, and insurance.
Professional summary
Brent Ahrens is a General Partner and West Coast healthcare investor at Canaan, where he has worked since 1999. He leads investments across healthcare with a focus on biopharma and medtech; prior to Canaan he worked in commercial and technical roles at General Surgical Innovations, Ethicon Endo-Surgery, and IAP Research. His firm bio lists current and prior investments including Abyrx, EndoGastric Solutions, Grey Wolf Therapeutics, Iterum Therapeutics, Pathios, Relievant Medsystems, Transposon Therapeutics, DexCom, Durata Therapeutics, and Peninsula Pharmaceuticals.
Selected portfolio companies the partner has backed
Career, education, and skills
12 more profiles